DentalGoodNews|Dental Credible Information Platform


韩国CG MedTech收购基台供应商,正式进入牙科修复市场

 
Issuing time:2025-05-26 15:16Author:编辑部
image.png

好的牙·讯|韩国骨科植入物研发制造公司CG MedTech近日宣布,与个性化牙科基台供应商All Abutment签署了收购协议,这是该公司继今年3月合并旗下数字牙科种植技术研发子公司GDS后,在加强数字牙科产品组合战略的又一重要举措。

此次签约仪式在CG MedTech总部举行,标志着该公司在完成数字种植技术布局后,进一步拓展至牙科修复市场。通过整合All Abutment的数字化制造能力与GDS的种植体研发技术,公司将实现从数字种植到个性化修复体的全周期自主生产能力。

image.png

根据公司声明,随着钛及氧化锆基修复技术的进步,市场对个性化基台需求持续增长,具备数字化设计能力与精密制造技术的企业正获得全球竞争优势。All Abutment凭借基于口腔扫描数据的高精度数控铣削技术,在个性化基台领域建立了技术壁垒,其产品能精准适配患者解剖结构。

CG MedTech首席执行官Yu Hyun-seung表示:“数字牙科正在通过口腔内扫描、CAD/CAM和3D打印技术显著提高治疗的准确性和效率,从而改变全球牙科格局。”通过此次收购,CG MedTech将构建覆盖设计、精密加工、质量管控到流通环节的数字化全流程体系。

关于CG MedTech:成立于1993年,是韩国一家专注于骨科植入物研究、开发和制造的上市公司。公司产品包括多种脊柱固定系统、骨移植替代品以及介入医疗设备,业务遍及美国、巴西、英国、南非、中国、日本等多个国家和地区。

关于All Abutment:于2016年在韩国城南市成立,公司主要生产数字基台,包括个性化基台、临时基台、CCM基台、Tibase 基台、多单元基台等。

(本内容图源:KBR、All Abutment)

Member Trending Reads

Member Trending Reads

副标题

Full - mouth denture restoration is included in medical insurance. The industry concentration is at a low level, and there is huge room for integration. Are you ready to embrace new opportunities?
Regulation: Not to restrict growth, but to weed out bad apples & protect good ones—let quality firms shine in fair competition!
"Cooling Momentum, Unwavering Resilience" – The Dental Industry Is Marching Toward "Quality Restoration"!
California's New Bill Sets Clear Boundaries for Dentists' Decision-Making Authority: How to Balance Clinical Autonomy Amid the Capitalization Wave?
Mental Health: A Casualty of the Healthcare System — Who Foots the Bill for Practitioners’ Physical & Mental Well-Being?
National Dental Expansion Rebounds | 940 Net New (Sep)—What’s the Future Potential?
Standardized Implants → Millimeter-Level Orthognathic Bone Resection: Robots Reshaping Dental Surgery’s Execution Logic & Tech Boundaries!
【GOODNEWS】 Content for industry reference only (based on public info & professional judgment); not for decision-making. Readers bear full responsibility for their own judgment and risks. Copyright © This Platform. Unauthorized reproduction & commercial use prohibited. Errata, contributions & cooperation: Contact customer service via WeChat:HDSW_001
✉️
Subscribe to Our
Newsletter
We curate important stories and exclusive insights, delivered straight to your inbox.
In-depth analysis · Exclusive content · Fast-moving news
1
Contact Us


Cooperation & Contact: haodeya@dongxizixun.com
Industry Updates

Industry Updates

副标题